Skip to main content

Twist Bioscience

Twist Bioscience Corp is an American synthetic biology provider manufacturing high-throughput synthetic DNA molecules. The company utilizes a silicon-based DNA synthesis platform to produce synthetic genes, oligonucleotide pools, next-generation sequencing target enrichment panels, and antibody libraries. Revenue is primarily generated through the sale of custom synthetic DNA products, library design tools, and research service contracts. Its end markets include academic research institutions, biotechnology firms, pharmaceutical developers, agricultural companies, and industrial chemical producers globally. Twist Bioscience holds a leading position in the synthetic biology sector through its proprietary miniaturized DNA manufacturing technology. The company is headquartered in South San Francisco, California, and its shares are listed on the Nasdaq Global Select Market.

12 of the funds FundTelligence covers report a position in Twist Bioscience.

Legal name
TWIST BIOSCIENCE CORP
Sector
Health Care
Country
United States
Funds holding it
12
Exposure themes
Genomics & Profiling, Genomic Tools, Precision Medicine & Genomics

Funds holding Twist Bioscience

Showing the 8 largest of 12 funds holding it.

Loading...